Invesco Pharmaceuticals ETF
PJP
97 hedge funds and large institutions have $194M invested in Invesco Pharmaceuticals ETF in 2016 Q2 according to their latest regulatory filings, with 14 funds opening new positions, 28 increasing their positions, 38 reducing their positions, and 8 closing their positions.
99% more call options, than puts
Call options by funds: $691K | Put options by funds: $348K
75% more first-time investments, than exits
New positions opened: 14 | Existing positions closed: 8
4% more funds holding
Funds holding: 93 → 97 (+4)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
0.68% less ownership
Funds ownership: 17.53% → 16.85% (-0.68%)
5% less capital invested
Capital invested by funds: $205M → $194M (-$11M)
26% less repeat investments, than reductions
Existing positions increased: 28 | Existing positions reduced: 38
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$7.53M |
| 2 |
MWM
Merriman Wealth Management
Seattle,
Washington
|
+$5.37M |
| 3 |
Bank of America
Charlotte,
North Carolina
|
+$5.3M |
| 4 |
Goldman Sachs
New York
|
+$3.75M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$1.96M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LPL Financial
San Diego,
California
|
-$24.5M |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$4.29M |
| 3 |
AIG
American International Group
New York
|
-$3.46M |
| 4 |
VF
Virtu Financial
New York
|
-$3.24M |
| 5 |
Wells Fargo
San Francisco,
California
|
-$1.92M |
PJP Hedge Fund Activity: Q2 2016 in Review
97 of the 3,756 institutional investors tracked by Wall St. Rank reported a position in Invesco Pharmaceuticals ETF (PJP) for Q2 2016, worth a combined $194M — down 5.4% from $205M a quarter earlier.
Buyers outnumbered sellers: 14 funds opened new PJP positions and 8 closed out — a net gain of 6 holders — while 28 added to existing stakes and 38 trimmed.
The largest buyer was UBS Group, adding an estimated $7.53M. The largest seller was LPL Financial, cutting an estimated $24.5M.
- 97 institutional investors held Invesco Pharmaceuticals ETF (PJP) as of Q2 2016, up from 93 in Q1 2016.
- Funds reported $194M of Invesco Pharmaceuticals ETF stock for Q2 2016, down 5.4% quarter-over-quarter.
- 14 funds opened new Invesco Pharmaceuticals ETF positions in Q2 2016 and 8 closed out, a net change of +6 holders.
- The largest Invesco Pharmaceuticals ETF buyer in Q2 2016 was UBS Group, an estimated $7.53M added.
- The largest Invesco Pharmaceuticals ETF seller in Q2 2016 was LPL Financial, an estimated $24.5M sold.
Based on aggregated 13F filings for Q2 2016.